Skip to main content

IMLEU22042 // PTG-300-11 // Maguire

Basic Study Information

The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms of PV.

Location: Wilmot Cancer Institute, University of Rochester

Lead Researcher (Principal Investigator)

Lead Researcher:  Craig Maguire

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email:

Additional Study Details

Return to Search